Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Chinas weight-loss drug makers take on global giants as Novo Nordisk patent expires Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
Customer service and refund issues Multiple complaints describe difficulty getting refunds and slow response times when issues arise
Fatigue is common initially as your body adjusts to fewer calories and changing blood sugar levels, and you should also monitor for any vision changes that may occur
doi: 10.13194/j.issn.1673-842x.2023.07.026 39 DunneCO'MahonyLMurphyLThorntonGMorrisseyDO'HalloranSet al
